Choline and Risk of Neural Tube Defects in a Folate-fortified Population

Epidemiology

Volumn 20, Issue 5, 2009, Pages 714-719

  Shaw, Gary M ^a   Finnell, Richard H ^a   Blom, Henk J ^b   Carmichael, Suzan L ^b   Vollset, Stein Emil ^c   Yang, Wei ^c   Ueland, Per M ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; FOLIC ACID; LIPOTROPIC AGENT;

ADULT; ARTICLE; BLOOD; DIET SUPPLEMENTATION; FEMALE; HUMAN; NEURAL TUBE DEFECT; PROSPECTIVE STUDY; RISK; RISK ASSESSMENT; UNITED STATES; UTILIZATION REVIEW;

ADULT; CALIFORNIA; CHOLINE; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; HUMANS; LIPOTROPIC AGENTS; NEURAL TUBE DEFECTS; ODDS RATIO; PROSPECTIVE STUDIES; RISK ASSESSMENT; YOUNG ADULT;

EID: 73349121672     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0b013e3181ac9fe7     Document Type: Article

References (40)

1. MRC-Vitamin-Study-Research-Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991;338:131-137.
2. Williams LJ, Mai CT, Edmonds LD, et al. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology. 2002;66:33-39.
3. Yates JR, Ferguson-Smith MA, Shenkin A, Guzman-Rodriguez R, White M, Clark BJ. Is disordered folate metabolism the basis for the genetic predisposition to neural tube defects? Clin Genet. 1987;31:279-287.
4. Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med. 1993;86:703-708.
5. Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med. 2000;343:1608-1614.
6. Ray JG, Blom HJ. Vitamin B12 insufficiency and the risk of fetal neural tube defects. QJM. 2003;96:289-295.
7. Shaw GM, Velie EM, Schaffer DM. Is dietary intake of methionine associated with a reduction in risk for neural tube defect-affected pregnancies? Teratology. 1997;56:295-299.
8. Velie EM, Block G, Shaw GM, Samuels SJ, Schaffer DM, Kulldorff M. Maternal supplemental and dietary zinc intake and the occurrence of neural tube defects in California. Am J Epidemiol. 1999;150:605-616.
9. Schorah CJ, Wild J, Hartley R, Sheppard S, Smithells RW. The effect of periconceptional supplementation on blood vitamin concentrations in women at recurrence risk for neural tube defect. Br J Nutr. 1983;49:203-211.
10. Shaw GM, Carmichael SL, Yang W, Selvin S, Schaffer DM. Periconceptional dietary intake of choline and betaine and neural tube defects in offspring. Am J Epidemiol. 2004;160:102-109.
11. Smithells RW, Sheppard S, Schorah CJ. Vitamin deficiencies and neural tube defects. Arch Dis Child. 1976;51:944-950.
12. Mills JL, Tuomilehto J, Yu KF, et al. Maternal vitamin levels during pregnancies producing infants with neural tube defects. J Pediatr. 1992;120:863-871.
13. Steen MT, Boddie AM, Fisher AJ, et al. Neural-tube defects are associated with low concentrations of cobalamin (vitamin B12) in amniotic fluid. Prenat Diagn. 1998;18:545-555.
14. Wald NJ, Hackshaw AK, Stone R, et al. Blood folic acid and vitamin B12 in relation to neural tube defects. Br J Obstet Gynaecol. 1996;103:319-324.
15. Economides DL, Ferguson J, Mackenzie IZ, et al. Folate and vitamin B12 concentrations in maternal and fetal blood, and amniotic fluid in second trimester pregnancies complicated by neural tube defects. Br J Obstet Gynecol. 1992;99:23-25.
16. Molloy AM, Kirke P, Hillary I, et al. Maternal serum folate and vitamin B12 concentrations in pregnancies associated with neural tube defects. Arch Dis Child. 1985;60:660-665.
17. Croen LA, Shaw GM, Jensvold NJ, Harris JA. Birth defects monitoring in California: a resource for epidemiologic research. Paediatr Perinat Epidemiol. 1991;5:423-427.
18. Ueland PM, Midttun O, Windelberg A, Svardal A, Skalevik R, Hustad S. Review: Quantitative profiling of folate and one-carbon metabolism in large-scale epidemiological studies by mass spectrometry. Clin Chem Lab Med. 2007;45:1737-1745.
19. Holm PI, Ueland PM, Kvalheim G, Lien EA. Determination of choline, betaine, and dimethylglycine in plasma by a high-throughput method based on normal-phase chromatography-tandem mass spectrometry. Clin Chem. 2003;49:286-294.
20. Zeisel SH. Choline: needed for normal development of memory. J Am Coll Nutr. 2000;19:528S-531S.
21. Zeisel SH, Blusztajn JK. Choline and human nutrition. Annu Rev Nutr. 1994;14:269-296.
22. Shronts EP. Essential nature of choline with implications for total parenteral nutrition. J Am Diet Assoc. 1997;97:639-646, 649.
23. Zeisel SH. Nutrigenomics and metabolomics will change clinical nutrition and public health practice: insights from studies on dietary requirements for choline. Am J Clin Nutr. 2007;86:542-548.
24. Zeisel SH. Choline, homcysteine, and pregnancy. Am J Clin Nutr. 2005;82:719-720.
25. Zeisel SH. Choline: essential for brain development and function. Adv Pediatr. 1997;44:263-295.
26. Van den Veyver IB. Genetic effects of methylation diets. Annu Rev Nutr. 2002;22:255-282.
27. Dunleavy LPE, Burren KA, Mills K, et al. Integrity of the methylation cycle is essential for mammalian neural tube closure. Birth Def Res A. 2006;76:544-552.
28. Fisher MC, Zeisel SH, Mar MH, Sadler TW. Pertubations in choline metabolism cause neural tube defects in mouse embryos in vitro. FASEB J. 2002;16:619-622.
29. Fisher MC, Zeisel SH, Mar MH, Sadler TW. Inhibitors of choline uptake and metabolism cause developmental abnormalities in neurulating mouse embryos. Teratology. 2001;64:114-122.
30. Wong L, Magdaleno S, Tabas I, Jackowski S. Early embryonic lethality in mice with targeted deletion of the CTP: phosphocholine cytidyltransferase a gene (Pcyt1a). Mol Cell Biol. 2005;25:3357-3363.
31. Wu G, Aoyama C, Young SG, Vance DE. Early embryonic lethality caused by disruption of the gene for choline kinase a, the first enzyme in phosphatidylcholine biosynthesis. J Biol Chem. 2008;283:1456-1462.
32. Harris MJ, Juriloff DM. Mini-review: toward understanding mechanisms of genetic neural tube defects in mice. Teratology. 1999;60:292-305.
33. Petzold A, Stiefel D, Copp AJ. Amniotic fluid brain-specific proteins are biomarkers for spinal cord injury in experimental myelomeningocele. J Neurochem. 2005;95:594-598.
34. Zhao W, Mosley BS, Cleves MA, Melnyk S, James SJ, Hobbs CA. Neural tube defects and maternal biomarkers of folate, homocysteine, and glutathione metabolism. Birth Defects Res A Clin Mol Teratol. 2006;76:230-236.
35. Mills JL, McPartlin JM, Kirke PN, et al. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet. 1995;345:149-151.
36. Van Der Put NM, van Straaten HW, Trijbels FJ, Blom HJ. Folate, homocysteine and neural tube defects: an overview. Exp Biol Med (Maywood). 2001;226:243-270.
37. Adams MJ Jr, Khoury MJ, Scanlon KS, et al. Elevated midtrimester serum methylmalonic acid levels as a risk factor for neural tube defects. Teratology. 1995;51:311-317.
38. Ray JG, Wyatt PR, Thompson MD, et al. Vitamin B12 and the risk of neural tube defects in a folic-acid-fortified population. Epidemiology. 2007;18:362-366.
39. Lawrence JM, Umekubo MA, Chiu V, Petitti DB. Split sample analysis of serum folate levels after 18 days in frozen storage. Clin Lab. 2000;46:483-486.
40. Benevenga NJ. Consideration of betaine and one-carbon sources of N5-methyltetrahydrofolate for use in homocystinuria and neural tube defects. Am J Clin Nutr. 2007;85:946-949.